entity

Ad Pathology

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Ad Pathology: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

17Connections

0Hypotheses

1Analyses

0Outgoing

17Incoming

0Experiments

2Debates

No AI portrait yet

Outgoing (0)

Target	Relation	Type	Str
No outgoing edges

Incoming (17)

Source	Relation	Type	Str
Aβ42:Aβ40 Ratio	biomarker_for	biomarker	0.93
Amyloid Probability Score 2	biomarker_for	biomarker	0.93
MAPT	associated_with	protein	0.92
41542441	does not result in	paper	0.90
39272998	has been proven to be a major contributor to	paper	0.90
39272998	is a major contributor to	paper	0.90
29552443	is less evident in NHD than	paper	0.90
29552443	is less evident in	paper	0.90
GFAP	indicates	protein	0.90
TREM2	regulates	protein	0.85
Excitatory Neurons	associated_with	cell_type	0.82
Cognitive Resilience	associated_with	phenotype	0.80
GFAP	regulates	gene	0.75
synaptic dysfunction	causes	mechanism	0.70
41942760	associated with	paper	0.60
31392412	spreads via	paper	0.60
41542441	no reduction in	paper	0.60

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (1)

Scientific analyses that reference this entity

Proteomics Differential Expression in AD CSF and Brain Tissue

neurodegeneration | 2026-04-16 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (2)

Multi-agent debates referencing this entity

Which proteins are differentially expressed in AD CSF and brain tissue, and do t

closed · Rounds: 4 · Score: 0.30 · 2026-04-21

Is a 12-protein CSF panel superior to existing plasma p-tau217 for clinical AD p

closed · Rounds: 4 · Score: 0.70 · 2026-04-16

Related Research

Hypotheses and analyses mentioning Ad Pathology in their description or question text

No additional research found